Using circulating tumor DNA (ctDNA) to predict surgical outcome and postoperative recurrence following neoadjuvant chemoradiation (CRT) for borderline resectable/locally advanced rectal cancer (LARC).
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Susan G.R. McDuff, Karin Hardiman, Aparna Raj Parikh, Peter Ulintz, Mehlika Hazar-Rethinam, Hui Zheng, Emily Van Seventer, Isobel Fetter, Brandon Nadres, David P. Ryan, Colin D. Weekes, Jeffrey W. Clark, James C. Cusack, Lipika Goyal, Andrew X. Zhu, Jennifer Yon-Li Wo, Lawrence Scott Blaszkowsky, Jill N. Allen, Ryan Bruce Corcoran, Theodore S. Hong
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2913189789